1
|
King CT, Gegg CV, Hu SNY, Sen Lu H, Chan BM, Berry KA, Brankow DW, Boone TJ, Kezunovic N, Kelley MR, Shi L, Xu C. Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor. ACS Pharmacol Transl Sci 2019; 2:485-490. [PMID: 32259079 DOI: 10.1021/acsptsci.9b00061] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Indexed: 01/05/2023]
Abstract
In 2018, the United States Food and Drug Administration (FDA) approved Aimovig (erenumab) for the prevention of migraine. Erenumab is the first FDA approved antibody therapeutic against a G-protein-coupled receptor, the canonical receptor of calcitonin gene related peptide (CGRP-R). A novel, epitope-focused antigen was created to reconstruct the extracellular domains of the CGRP-R in a stable conformation. Successful inoculation of XenoMouse animals and careful screening yielded multiple candidate molecules for high potency and exquisite selectivity toward the CGRP-R over related receptors. These efforts led to the discovery of erenumab which has demonstrated the desired efficacy and safety profiles in multiple clinical studies for the prevention of migraine. The innovation developed in the discovery of erenumab furthers the ability to target G-coupled protein receptors using antibody approaches.
Collapse
Affiliation(s)
- Chadwick Terence King
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Colin V Gegg
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Sylvia Nai-Yu Hu
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Hsieng Sen Lu
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Brian M Chan
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Kelly A Berry
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - David W Brankow
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Tom J Boone
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Nebojsa Kezunovic
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Matt R Kelley
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Licheng Shi
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| | - Cen Xu
- Amgen Research, 1 Amgen Center Drive, Thousand Oaks, California 91320-1799, United States
| |
Collapse
|
3
|
Zeng LF, Wang Y, Kazemi R, Xu S, Xu ZL, Sanchez TW, Yang LM, Debnath B, Odde S, Xie H, Zheng YT, Ding J, Neamati N, Long YQ. Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties. J Med Chem 2012; 55:9492-509. [DOI: 10.1021/jm300667v] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- Li-Fan Zeng
- State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
| | - Yong Wang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
| | - Roza Kazemi
- Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States
| | - Shili Xu
- Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States
| | - Zhong-Liang Xu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
| | - Tino W. Sanchez
- Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States
| | - Liu-Meng Yang
- Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming
Institute of Zoology, Chinese Academy of Sciences, Kunming 650223,
China
| | - Bikash Debnath
- Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States
| | - Srinivas Odde
- Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States
| | - Hua Xie
- State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
| | - Yong-Tang Zheng
- Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming
Institute of Zoology, Chinese Academy of Sciences, Kunming 650223,
China
| | - Jian Ding
- State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
| | - Nouri Neamati
- Department of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Southern California, 1985
Zonal Avenue, Los Angeles, California 90089, United States
| | - Ya-Qiu Long
- State Key Laboratory of Drug Research, Shanghai Institute of Materia
Medica, Shanghai Institutes for Biological Sciences, Chinese Academy
of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China
| |
Collapse
|